ABCC5 and type 2 diabetes mellitus: Over-expression of a human ABCC5 variant in subcutaneous fat was shown to correlate with T2DM (three-fold risk increase) and related phenotypes (beta cell function, peripheral insulin sensitivity, fasting IGR, and visceral fat) in European and African populations [9].